Early Automated Insulin Delivery (AID) Pilot for Newly Diagnosed T1D

Starting soon · Not applicable

Conditions studied: Type 1 Diabetes

In brief

Type 1 diabetes is a common chronic medical condition among youth in the US that requires intensive glycemic management to prevent long-term morbidity and mortality. Current pediatric diabetes care in the US underutilizes automated insulin delivery (AID) systems, which are the best available tools for promoting tight glycemic control while reducing user burden. This proposal aims to support early and sustained use of AID systems by examining and optimizing conditions, evaluating glycemic outcomes, and identifying contextual facilitators and barriers of implementation.

Key facts

Study ID

NCT07501338

Run by

Stanford University

People needed

16

Starts

2026-03-01

Expected to finish

2031-03-01

Last updated by the study team

2026-03-30

Who can join

Age: 2 and older, up to 26. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Recent clinical diagnosis of type 1 diabetes within the past 2 weeks
• intent to follow at Stanford Children's Pediatric Diabetes Clinic for clinical care

You may not qualify if…

• Does not have a clinical diagnosis of Type 1 diabetes
• Does not follow at Stanford Children's Pediatric Diabetes Clinic for clinical care

Where it is running

• Stanford Children's — Palo Alto, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.